Steven Xue
General Practice · Houston, TXNPI 1083839278
Payments from drug & device makers
Across 67 payments — averaging $279.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dentalez Alabama, Inc.$12K
- Dentalez, Inc.$2K
- Sirona Dental, Inc.$2K
- Dentsply Sirona Inc$1K
- Straumann USA LLC$473
- Biolase, Inc.$440
- plus $1K from 13 others
What the payments were for
- Food & beverage$3,50619%
- Education$1,2927%
- Gifts$13,91074%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dentalez Alabama, Inc. | 2 | $11,616 |
| Dentalez, Inc. | 4 | $2,467 |
| Sirona Dental, Inc. | 2 | $1,500 |
| Dentsply Sirona Inc | 9 | $1,087 |
| Straumann USA LLC | 16 | $473 |
| Biolase, Inc. | 8 | $440 |
| Zimmer Biomet | 4 | $295 |
| Henry Schein, Inc. | 4 | $146 |
| Carestream Dental, LLC | 1 | $133 |
| Meisinger USA, LLC | 1 | $125 |
| Nobel Biocare USA | 2 | $96 |
| Zimvie Inc. | 5 | $92 |
| Keystone Dental Inc. | 3 | $78 |
| Align Technology, Inc. | 1 | $58 |
| Dental Imaging Technologies Corp. | 1 | $35 |
| VOCO America Inc. | 1 | $23 |
| Kulzer, LLC | 1 | $17 |
| Geistlich Pharma, North America, Inc. | 1 | $14 |
| Kuraray America Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Aeras 500 Elite LubeFree, fiber optic and Aeras 500 Swivel fiber optic$2,299
- CEREC$1,500
- ORTHOPHOS$1,500
- 2638$125
- Tapered Screw$120
- Waterlase iPlus, Epic, iLase$105
How this compares
$18,707 in reported general payments places this provider in the 95th percentile of 8,074 general practice providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Chlorhexidine Gluconate | 182 | $404 |
| Amoxicillin | 208 | $403 |
| Clindamycin Hcl | 55 | $268 |
| Ibuprofen | 152 | $255 |
| Methylprednisolone | 47 | $176 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 24 | $117 |
| Azithromycin | 24 | $50 |
Paid to pharmacies, not to this prescriber.
Other general practice in Houston
- Helen ShpatsHouston$3.3M
- Kelechi AzuoguHouston$2.5M
- Kathleen Szelei-StevensHouston$253K
- Zsolt GaramiHouston$111K
- Jesus MayorHouston$105K
- Azim KarimHouston$98K
- Scott ColemanHouston$87K
- Rispba McCray-GarrisonHouston$70K
- Piya GandhiHouston$36K
- Terri AlaniHouston$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.